News
Where Roivant Sciences Stands With Analysts
25 Mar 24
Analyst Ratings
Truist Securities Reiterates Buy on Roivant Sciences, Maintains $23 Price Target
25 Mar 24
News, Price Target, Reiteration, Analyst Ratings
5 Value Stocks In The Healthcare Sector
19 Feb 24
News
Wolfe Research Initiates Coverage On Roivant Sciences with Outperform Rating, Announces Price Target of $17
15 Feb 24
News, Price Target, Initiation, Analyst Ratings
The Analyst Landscape: 4 Takes On Roivant Sciences
14 Feb 24
Analyst Ratings
HC Wainwright & Co. Maintains Buy on Roivant Sciences, Lowers Price Target to $17
14 Feb 24
News, Price Target, Analyst Ratings
Roivant Sciences Q3 2024 Adj EPS $(0.21) Beats $(0.32) Estimate, Sales $37.14M Beat $32.79M Estimate
13 Feb 24
Earnings, Earnings Beats, News
Earnings Scheduled For February 13, 2024
13 Feb 24
Earnings
Roivant Sciences Earnings Preview
12 Feb 24
Earnings
Analyst Highlights Aclaris Therapeutics' Encouraging Efficacy For Eczema Candidate, But Cautions On Data Variations
10 Jan 24
Analyst Color, Biotech, News, Penny Stocks, Health Care, Analyst Ratings, General
Piper Sandler Initiates Coverage On Roivant Sciences with Overweight Rating, Announces Price Target of $20
5 Jan 24
News, Price Target, Initiation, Analyst Ratings
Assessing Roivant Sciences: Insights From 5 Financial Analysts
2 Jan 24
Analyst Ratings
B of A Securities Maintains Neutral on Roivant Sciences, Raises Price Target to $12
2 Jan 24
News, Price Target, Analyst Ratings